AI-powered medical devices are linked to injuries, recalls, and lawsuits as regulators struggle to oversee a fast-growing ...

IMPACT DUCHENNE is a Phase 3 randomized, double-blind, placebo-controlled trial to evaluate the efficacy of a single dose of ...

Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), announces it will be ...

India’s startup policy framework has taken a notable step away from one-size-fits-all definitions. With the latest notification, the Department for Promotion of Industry and Internal Trade (DPIIT) has ...

Ladies and gentlemen, welcome to Avery Dennison's earnings conference call for the fourth quarter ended on December 31, 2025. [Operator Instructions] As a reminder, this webcast is being recorded and ...

Yuri Bender is a journalist covering banking, asset management and capital markets. He has launched and edited several ...

Womanhood, Faith, Sexuality. Survival,' is a collection of narrative nonfiction portraits drawn from the body of investigative work by 'Sex and Sensibility' columnist Ana Santos ...

From a formulation perspective, Garaherb emphasizes botanical ingredients historically associated with male vitality, physical endurance, and metabolic efficiency. These components are combined with ...

What you need to know: While such comparisons are inevitable, they must be approached with caution, depth, and a clear understanding of what examination results truly represent. The release of the ...

New research shows MDMA and psilocybin may restore neural flexibility in people with PTSD, thereby helping the brain unlearn ...

Detailed price information for Aquestive Therapeutics Inc (AQST-Q) from The Globe and Mail including charting and trades.

Good afternoon, everyone, and welcome to our fourth quarter 2025 earnings call. Bob Bradway will lead the call today and be followed by a broader review of our performance by Jay Bradner, Murdo Gordon ...